MedTrace Logo

Defining Benchmarks for Gastric Cancer Patients Underwent Minimal Invasive Gastrectomy

NCT06938139 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 90000

Last updated 2025-04-22

No results posted yet for this study

Summary

The Benchmark-MISGC study was a large-scale retrospective observational study launched by the China Gastric Cancer Surgical Union, aiming to establish the benchmarks of the short- and long-term outcomes for gastric cancer patients who underwent minimal invasive gastrectomy.

Conditions

  • Gastric Adenocarcinoma
  • Surgery, Laparoscopic

Interventions

OTHER

None-placebo

None, observational study

Sponsors & Collaborators

  • Fujian Medical University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-01
Primary Completion
2025-04-30
Completion
2025-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06938139 on ClinicalTrials.gov